-+ 0.00%
-+ 0.00%
-+ 0.00%

iRadimed Sees Q2 GAAP EPS $0.40-$0.44 vs $0.42 Est

Benzinga·05/01/2026 12:33:42
Listen to the news
iRadimed (NASDAQ:IRMD) is looking for Q2 GAAP EPS of $0.40-$0.44 vs $0.42 analyst estimate..